Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nike
NKE
5
Palantir
PLTR
JP Stock MarketDetailed Quotes
2160 GNI Group
- 1741
- -141-7.49%
20min DelayMarket Closed Apr 4 15:30 JST
87.43BMarket Cap82.32P/E (Static)
1860High1636Low5.25MVolume1846Open1882Pre Close9.05BTurnover397052wk High11.08%Turnover Ratio50.22MShares153752wk Low21.15EPS TTM82.45BFloat Cap4070Historical High82.32P/E (Static)47.36MShs Float13Historical Low21.15EPS LYR11.90%Amplitude--Dividend TTM2.40P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees867
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Toshiya Kitagawa
- Director, Executive Officer and Chief Financial Officer
- --
- Sekitani Kazuki
- Director, Executive Officer and Chief Operating Officer
- --
- Thomas Eastling
- Director
- --
- Ryosuke Matsui
- Director
- --
- Kikuchi Kanako
- Independent Director
- --
- Zhang Ping
- Independent Director
- --
- Hideaki Sashiwa
- Independent Director
- --